Vimedimex Medi-Pharma JSC (HOSE:VMD)
Vietnam · Delayed Price · Currency is VND 15,000
+50 (0.33%)
At close: Apr 29, 2026
Vimedimex Medi-Pharma JSC Cash Flow Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Net Income | 42,361 | 23,194 | 25,482 | 34,818 | 19,995 |
Depreciation & Amortization | 3,958 | 19,638 | 18,792 | 19,251 | 19,051 |
Other Amortization | - | - | 604.9 | - | 369.31 |
Loss (Gain) From Sale of Assets | -7,977 | -6,457 | -15,631 | -7,121 | - |
Loss (Gain) From Sale of Investments | - | - | - | - | -5,531 |
Other Operating Activities | -1,893 | 6,129 | 1,431 | -3,364 | -29,865 |
Change in Accounts Receivable | -1,039,280 | 367,260 | 551,782 | 1,378,506 | 1,182,198 |
Change in Inventory | 70,331 | 162,999 | 698,451 | 1,593,122 | 1,367,202 |
Change in Accounts Payable | 943,064 | -459,010 | -1,266,375 | -2,310,209 | -2,979,235 |
Change in Other Net Operating Assets | - | 4,921 | 7,333 | -2,920 | 3,799 |
Operating Cash Flow | 10,565 | 118,674 | 21,872 | 702,082 | -422,016 |
Operating Cash Flow Growth | -91.10% | 442.59% | -96.89% | - | - |
Capital Expenditures | - | -7,001 | -16,329 | -5,163 | -20,468 |
Sale of Property, Plant & Equipment | - | - | 4.82 | 166.54 | 10.09 |
Investment in Securities | - | - | - | -1,380 | - |
Other Investing Activities | 6,836 | 6,457 | 11,000 | 6,263 | 14,727 |
Investing Cash Flow | -183,044 | 4,084 | -2,278 | -11,650 | -5,673 |
Short-Term Debt Issued | - | - | - | - | 1,736,174 |
Long-Term Debt Issued | - | - | 338,500 | 634,900 | - |
Total Debt Issued | - | - | 338,500 | 634,900 | 1,736,174 |
Short-Term Debt Repaid | - | - | - | - | -1,468,800 |
Long-Term Debt Repaid | - | - | -338,500 | -1,247,274 | - |
Total Debt Repaid | - | - | -338,500 | -1,247,274 | -1,468,800 |
Net Debt Issued (Repaid) | - | - | - | -612,374 | 267,374 |
Issuance of Common Stock | - | - | 6,710 | 2,000 | 46,410 |
Common Dividends Paid | - | -31,443 | -30,178 | -15,116 | -40,067 |
Other Financing Activities | - | - | - | - | 0 |
Financing Cash Flow | - | -31,443 | -23,468 | -625,490 | 273,717 |
Foreign Exchange Rate Adjustments | - | - | - | -12.15 | -0.74 |
Miscellaneous Cash Flow Adjustments | - | - | - | - | 0 |
Net Cash Flow | -172,479 | 91,315 | -3,875 | 64,930 | -153,973 |
Free Cash Flow | 10,565 | 111,673 | 5,543 | 696,919 | -442,484 |
Free Cash Flow Growth | -90.54% | 1914.81% | -99.20% | - | - |
Free Cash Flow Margin | 1.30% | 8.94% | 0.16% | 9.85% | -3.59% |
Free Cash Flow Per Share | 684.23 | 7232.56 | 358.89 | 45136.46 | -28657.78 |
Cash Interest Paid | - | 3,703 | 1,749 | 7,612 | 13,200 |
Cash Income Tax Paid | 6,241 | 6,306 | 13,709 | 5,057 | 15,850 |
Levered Free Cash Flow | 84,166 | 90,510 | 10,091 | 690,144 | -384,347 |
Unlevered Free Cash Flow | 84,166 | 92,825 | 11,184 | 693,335 | -374,507 |
Change in Working Capital | -25,885 | 76,171 | -8,808 | 658,498 | -426,036 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.